Clinical Trial Update: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LT3001 for acute ischemic stroke is currently recruiting. The study aims to assess the drug's efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• LT3001

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING